Omega-3-carboxylic acids Completed Phase 2 Trials for Exocrine Pancreatic Insufficiency / Type 2 Diabetes Mellitus Treatment

CompletedTreatment2 IdentifierTitleDrugs
NCT02370537A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI